Mr. Gan · haixiao@sungolytest.com · +86 158 2169 5110 · +86 132 4819 8029Mr. Luo · jun.luo@sungoglobal.com · +86 177 5560 4650

QNC

Whole Exome Sequencing Constituent Device

Product code
QNC
Device name
Whole Exome Sequencing Constituent Device
Device class
Class 2
21 CFR
21 CFR 866.6000
Medical specialty
Medical Genetics
Marketing pathway
510(K)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

A whole exome sequencing constituent device is for germline whole exome sequencing of genomic deoxyribonucleic acid (DNA) isolated from human specimens. The DNA sequence generated by this device is intended as input for clinical germline DNA assays that have FDA marketing authorization and are intended for use with this device.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: QNC
Classification and pathway per current FDA publications. Data from openFDA (CC0).